Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
about
Prevention and Treatment of Recurrent Hepatitis B after Liver TransplantationHyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.Current use of hepatitis B immune globulin for prevention of de novo hepatitis B in recipients receiving anti-HBc-positive livers.Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxisPrevention of hepatitis B recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis B immunoglobulin.Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation.Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review.The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation.Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.Hepatitis B immune globulin in liver transplantation prophylaxis: an update.High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.Hepatitis B immunoglobulin prophylaxis after liver transplantation: experience in a tertiary transplant centreAnti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients.
P2860
Q26751777-C9238D78-FF25-40F2-9124-92A557209E99Q33624284-3541E9DC-8E5B-4A53-AFCD-E20027F88013Q34959703-A6800094-23DD-49FF-9C04-69878DC5A706Q35549423-C3D11CF1-643D-4730-BBF3-EB14E022ECE8Q35582445-C2539AFB-B393-408B-9DBE-63C496799AD9Q37468277-EC520A70-3B6D-479E-B469-C5A951E28790Q37495757-D584E948-3A36-44BB-8B35-DC6C6BFE4B4FQ37764964-99E20382-31AB-40BB-B585-BD2B9E5B6AFEQ37870833-E1862812-5FFF-4B71-B05E-E67B5465D3E0Q37886893-7B5A887E-3146-4C1B-AEDE-0FFB5C335481Q38006958-D245929F-7E3B-4927-BC7A-FAFE1CBD6AA9Q38058545-DA8B0FCB-769B-40F8-9EC3-2EC6D570461FQ41835680-9991D2B9-E8ED-40D6-9DBE-B73730966963Q42222635-BB006D38-4500-4265-A287-F7B30305259B
P2860
Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Low-dose intramuscular hepatit ...... e after liver transplantation.
@en
Low-dose intramuscular hepatit ...... e after liver transplantation.
@nl
type
label
Low-dose intramuscular hepatit ...... e after liver transplantation.
@en
Low-dose intramuscular hepatit ...... e after liver transplantation.
@nl
prefLabel
Low-dose intramuscular hepatit ...... e after liver transplantation.
@en
Low-dose intramuscular hepatit ...... e after liver transplantation.
@nl
P2093
P50
P1476
Low-dose intramuscular hepatit ...... ce after liver transplantation
@en
P2093
Callejon V
Ferretti G
Ferretti S
Iappelli M
Rivanera D
Tanzilli P
P304
P356
10.1016/J.TRANSPROCEED.2004.02.025
P407
P577
2004-04-01T00:00:00Z